Skip to main content

Table 2 Univariate analysis for luminal types (ILC and IDC)

From: Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma

  DFS OS
Variables HR (95 % CI) P-value HR (95 % CI) P-value
Age     
50 1.0   1.0  
  < 50 1.14(0.80–1.64) 0.455 1.17(0.65–2.11) 0.591
Menopause status     
 Post 1.0   1.0  
 Pre 1.06(0.75–1.51) 0.708 1.20(0.68–2.11) 0.513
Tumor size     
  < 2 1.0   1.0  
 2 ≤ T < 5 3.82(2.62–5.58)   6.08(3.19–11.57)  
 5≥ 8.24(4.72–14.39) <0.001 11.81(4.74–29.42) <0.001
Lymph node status     
 Negative 1.0   1.0  
 Positive 3.51(2.40–5.12) <0.001 6.26(3.17–12.36) <0.001
Pathology type(ILC,IDC)     
 IDC 1.0   1.0  
 ILC 2.06(1.18–3.60) 0.008 2.48(1.05–5.84) 0.030
Histological grade     
 1 1.0   1.0  
 2 1.98(1.19–3.31)   2.03(0.82–5.00)  
 3 4.41(2.53–7.70) <0.001 5.52(2.15–14.12) <0.001
  1. IDC invasive ductal carcinoma, ILC invasive lobular carcinoma, DFS disease free survival, OS overall survival, HR hazard ratio, 95 % CI 95 % confidence interval